Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 CNR1 [4] Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling D10915 Cannabidiol [19] 2, 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
2 CNR2 [1] Neuroactive ligand-receptor interaction D10915 Cannabidiol [8] 145, 156, 157, 158, 193, 206, 226, 271
3 ABAT [7] Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse D00535 Vigabatrin [2] 145, 158
4 GABRA1 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
5 GABRA2 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
6 GABRA3 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
7 GABRA4 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
8 GABRA5 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
9 GABRA6 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
10 GABRB1 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
11 GABRB2 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
12 GABRB3 [6] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
13 GABRD [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
14 GABRE [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
15 GABRG1 [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
16 GABRG2 [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
17 GABRG3 [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
18 GABRP [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
19 NR3C1 [1] Neuroactive ligand-receptor interaction D00407 Methylprednisolone [13] 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
20 NR3C1 [1] Neuroactive ligand-receptor interaction D00472 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
21 NR3C1 [1] Neuroactive ligand-receptor interaction D00751 Methylprednisolone [13] 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
22 NR3C1 [1] Neuroactive ligand-receptor interaction D00979 Methylprednisolone [13] 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
23 NR3C1 [1] Neuroactive ligand-receptor interaction D00980 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
24 NR3C1 [1] Neuroactive ligand-receptor interaction D00981 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
25 NR3C1 [1] Neuroactive ligand-receptor interaction D00982 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
26 NR3C1 [1] Neuroactive ligand-receptor interaction D01239 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
27 NR3C1 [1] Neuroactive ligand-receptor interaction D01998 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
28 NR3C1 [1] Neuroactive ligand-receptor interaction D02156 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
29 NR3C1 [1] Neuroactive ligand-receptor interaction D03301 Prednisolone [9] 145, 162, 222, 269, 271, 296, 299, 300, 307
30 NR3C1 [1] Neuroactive ligand-receptor interaction D05000 Methylprednisolone [13] 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
31 NR3C1 [1] Neuroactive ligand-receptor interaction D05001 Methylprednisolone [13] 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
32 NR3C1 [1] Neuroactive ligand-receptor interaction D05002 Methylprednisolone [13] 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
33 HTR2A [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D07945 Fenfluramine [4] 140, 144, 145, 149
34 HTR2B [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D07945 Fenfluramine [4] 140, 144, 145, 149
35 HTR2C [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels D07945 Fenfluramine [4] 140, 144, 145, 149
36 MC2R [5] cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome D00146 Corticotropin [15] 2, 13, 14, 46, 49, 50, 66, 75, 78, 81, 84, 145, 193, 205, 222
37 MC2R [5] cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome D00284 Tetracosactide [5] 78, 83, 113, 145, 222
38 MTNR1A [2] Neuroactive ligand-receptor interaction, Circadian entrainment D08170 Melatonin [12] 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
39 MTNR1B [2] Neuroactive ligand-receptor interaction, Circadian entrainment D08170 Melatonin [12] 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
40 GABRQ [5] Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction D04300 Ganaxolone [4] 145, 152, 158, 206
41 SLC6A4 [2] Synaptic vesicle cycle, Serotonergic synapse D07945 Fenfluramine [4] 140, 144, 145, 149